dannykwells

Except that lean verification means that you really need to just verify the lean problem statement right?

Well you can’t verify a prediction about human biology without a phase 3 clinical trial so…

From Bloomberg:

The overwhelming majority of the net loss in the first half of this year, $72 billion, resulted from accounting charges linked to changes in the value of convertible notes and other instruments Anthropic has issued, according to the report.

So this is really just capped notes converting. Total nothing burger.

I wish Terry the best.

This a thousand times. Thank you.

Also Bingo.

Bingo.

Yes exactly!!!

Bingo. The goal is positioning a duopoly / cartel as the only “safe” and “moral” path and then that cartel sets pace and price.

Slop

Tamarind is the best! Truly a YC company that provides true, bona fide value to biologists like us. (Hi Sherry!)

This is what I come here for.

A plot line literally out of a Final Destination movie (the newest one). MRI machines are scary!

Can someone explain to me - assuming they have enough data - why not train different models explicitly for each group / subgroup you want to model? You even could then just take the top N% of each group by score, effectively guaranteeing equal treatment for each group. Why would this not work?

This is honestly a fantastic outcome.

Regeneron is among the most science and data focused biopharma and has a long, long history in genetics. They know how critical privacy is and will ensure the data are used to advance human health.

Potentially an even better home for the data than in the company, since now will not have pressure of quarterly reports.